Skip to main content
[Preprint]. 2021 Sep 7:2021.09.03.21262934. [Version 1] doi: 10.1101/2021.09.03.21262934

Table:

Progression of COVID-19 symptoms

Symptom On enrollment Persistent at follow-up New at followcup
Cardiovascular
Chest Pain 34.2% (53/155) 11.3% (6/53) 0.7% (1/149)
Palpitations 0.6% (1/155) 0 (0) 1.3% (2/155)
Dermatologic
Rash 1.3% (2/155) 0 (0) 0.6% (1/155)
Hair Loss 0 (0) 0 (0) 0.6% (1/155)
Gastrointestinal
Nausea/vomiting/diarrhea 43.8% (68/155) 7.3% (5/68) 0.7% (1/150)
Constitutional
Fever 64.5% (100/155) 1.0% (1/100) 0 (0)
Chills 32.9% (51/155) 3.9% (2/51) 0.6% (1/153)
Myalgia 41.2% (64/155) 15.6% (10/64) 4.1% (6/145)
Fatigue 36.7% (57/155) 14.0% (8/57) 8.2% (12/147)
Neuropsychiatric
Loss of Taste 41.2% (64/155) 14.0% (9/64) 0 (0)
Loss of Smell 29.6% (46/155) 19.5% (9/46) 0 (0)
Confusion 2.5% (4/155) 0 (0) 2.6% (4/155)
Headache 22.5% (35/155) 2.8% (1/35) 5.2% (8/154)
Dizziness 5.8% (9/155) 22.2% (2/9) 2.6% (4/153)
Insomnia 0.6% (1/155) 0 (0) 0.6% (1/155)
Anxiety 0 (0) 0 (0) 1.3% (2/155)
Respiratory
Cough 72.2% (112/155) 25.8% (29/112) 3.9% (5/126)
Shortness of breath 65.1% (101/155) 18.8% (19/101) 3.7% (5/136)